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Available online 2 April 2016Objective: A bicuspid aortic valve (BAV) is associated with accelerated aortic valve disease (AVD) and abnormal-
ities in aortic elasticity. We investigated the intima-media thickness of the descending aorta (AoIMT) in patients
with AVDwith orwithout an ascending aortic aneurysm (AscAA), in relation to BAV versus tricuspid aortic valve
(TAV) phenotype, type of valve disease, cardiovascular risk factors, and single-nucleotide polymorphisms (SNPs)
with a known association with carotid IMT.
Methods and results: 368 patients (210with BAV, 158with TAV,); mean age 64±13 years) were examined using
transesophageal echocardiography (TEE) before valvular and/or aortic surgery. No patient had a coronary disease
(CAD). The AoIMT was measured on short-axis TEE images of the descending aorta using a semi-automated edge-
detection technique. AoIMTwasunivariately (Pb 0.05) related to age, bloodpressure, smoking, creatinine, highly sen-
sitive C-reactive protein, HDL, valve hemodynamics and BAV. In the TAV subgroup it was also associated with the
rs200991 SNP. Usingmultivariate regression analysis, agewas themain determinant for AoIMT (P b 0.001), followed
by male gender (P = 0.02), BAV was no longer a signiﬁcant predictor of AoIMT. AoIMT was still related to the
rs200991 SNP in TAV (P=0.034), and to creatinine in BAV (P=0.019), when other variables were accounted for.
Conclusions: Intima-media thickness of the descending aorta is not affected by aortic valve morphology (BAV/TAV);
age is the main determinant of AoIMT. Genetic markers (SNPs) known to inﬂuence IMT in the carotid artery seem
to correlate to IMT in the descending aorta only in patients with TAV.
© 2016 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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A bicuspid aortic valve (BAV) is prone to accelerated valve calciﬁca-
tion leading to premature aortic valve disease (AoVD) and is associated
with altered elastic properties [1–3], aneurysms (AscAA) [4,5], and dis-
section of the ascending aorta [6]. Wall changes in the ascending aorta
correlating to the ﬂow jet pattern in BAV patients with AoVD have
been described [7]. Although the disturbances in ﬂow in BAV have
been demonstrated in the entire aorta, including the descending aorta
[8], there are only a scarce number of studies on descending aortic func-
tion and morphology [9–11].
Intima-media thickness (IMT) in the descending aorta (AoIMT) has
been studied in relation to coronary artery disease (CAD) and strokeMedicine and Surgery L1:00,
.
land Ltd. This is an open access articl[12]. Non-laminar ﬂow has been shown to affect the IMT, triggeringmi-
gration of smoothmuscle cells andmonocytes aswell as causing intimal
hyperplasia [13,14]. To our knowledge, there are no reports examining
the AoIMT in patients with a BAV versus those with a tricuspid aortic
valve (TAV), or its relation to different hemodynamic environments
due to different aortic valve and aortic pathologies. Therefore, we exam-
ined the relationship between AoIMT and aortic valve phenotype (BAV/
TAV) and type of AoVD. We also tested its possible relation to some
single-nucleotide polymorphisms (SNPs) recently reported to inﬂuence
carotid intima-media thickness (CIMT) [15].
2. Methods
2.1. Study population
The initial population comprised 400 patients included in the Ad-
vanced Study of Aortic Pathology (ASAP), which is a prospectivee under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Stockholm, Sweden. Consecutive patients aged 18 years or over with
AoVD and/or anAscAA that required elective surgerywere recruited, pro-
vided they were willing to participate and free of CAD according to coro-
nary angiography. Prior to surgery, transesophageal echocardiography
(TEE)was performedon386patients under general anesthesia. Segments
with aortic plaque were excluded, why 8 patients could not be analyzed.
Further, 9 patients were excluded due to suboptimal image quality while
the AoIMT could bemeasured in 369 patients, constituting 96% of the TEE
sample. Characteristics of different subgroups of patients included in this
study were described previously [11]. On inclusion, patients answered a
questionnaire to assess cardiovascular risk factors. The systolic blood
pressure (SBP) and diastolic blood pressure (DBP) were measured, and
blood sampleswere taken for biochemical analyses. Themeanbloodpres-
sure (MBP)was calculated asMBP=DBP+1/3 (SBP–DBP). Classiﬁcation
of the valve phenotype was made by visual inspection of the valve intra-
operatively by the surgeon. Three cusps and three commissures signiﬁed
a TAV; two cusps and two commissures -with or without a raphe - signi-
ﬁed a BAV. This informationwasmissing in one case, so 368patientswere
included in the ﬁnal subgroup analysis. Each subject gavewritten consent
for participation in the study, which was approved by the Regional Ethics
Review Board, Stockholm, Sweden.
2.2. Transthoracic echocardiography (TTE)
All but three patients underwent TTE before surgery, using a Philips
iE33 ultrasound scanner (Philips Medical Systems, Bothell, WA, USA).
Doppler and two-dimensional echocardiography measurements were
performed according to the current standards (ASE 2005, 2009) [16,17].
Aortic regurgitation (AR) was graded as 0–3 (0, none; 1, mild; 2, moder-
ate; 3, severe) according to the 2003ASE guidelines [18], the PISAmethod
was not used for classiﬁcation. The patients were classiﬁed according to
ﬁndings on TTE into four groups: aortic stenosis (AS), AR, AscAA, or
with combined disease (MIX). Three patients could not perform TTE
and therefore could not be classiﬁedpreoperatively by this studyprotocol
due to logistics. The lesion was deﬁned as AS when the peak gradient
(Pmax) N 50mmHg andmean gradient (Pmean) N 40mmHg, and/or aortic
valve area b 1 cm2. AR was deﬁned as an AR grade = 3 not fulﬁlling the
AS criteria. AscAA was deﬁned as an ascending aortic diameter of 45 or
50 mm (BAV or TAV groups, respectively) and not fulﬁlling the criteria
for AS or AR. The MIX group consisted of patients with disease, which
did not fulﬁll the criteria for AS, AR, or AscAA above, based on the results
of TTE performedwithin the study protocol [19]. In patients being allocat-
ed to the MIX group TTE results differed from the primary evaluation
mostly due to the fact that additional diagnostic modalities have been in-
corporated or different examination conditions inﬂuenced the results at
the time of clinical decision making regarding cardiac surgery.
2.3. Transesophageal echocardiography
TEEwas performed in the operating roomwith the patient under gen-
eral anesthesia before surgery using a Sequoia c512 ultrasound scanner
(SiemensMedical Systems,MountainView, CA, USA)with transducer fre-
quency of 6 or 7 MHz, mean frame rate 70 Hz. The ECG was recorded on
the ultrasound images. Scanning of the descending aorta was performed
in short-axis view at three predeﬁned distances from the teeth (30, 35,
40 cm), with the 35 cm level approximately representing the level of
the left atrium in the majority of patients as described previously [11].
The gain settings were adjusted to obtain an optimal quality of the
image. From the three levels, we selected the level (preferably 35 cm)
with the best-deﬁned intima-media interface for measurement. Aortic
valve morphology (BAV/TAV) using TEE images was determined accord-
ing to the classiﬁcation of Sievers and Schmidtke [20].
All the TTE and TEE examinations were read by highly experienced
physicians working at the echo lab. For the TTE, all exams were dividedamong a group of 4 physicians. The TEE images were interpreted and
IMT measurements were performed by one single reader.
2.4. Intima-media thickness of descending aorta
Measurements of AoIMT were performed off-line using a Syngo Ar-
terialHealth Package semi-automated edge-detection program(version
3.5; Siemens Medical Systems), allowing detection of the echogenic
lines of the intima-media complex in a 10-mm-wide segment that
could be adjusted to the curvature of the vessel in short axis (Fig. 1).
The best-quality end-diastolic imagewith good perpendicular align-
ment was selected and a region of interest (ROI) was placed manually
over the far wall of the descending aorta in short-axis view. The ROI
length was set shorter than 10 mm in a small number of patients be-
cause of suboptimal image quality. Tracings of the intima-blood and
media-adventitia borders were adjusted manually when needed. The
mean AoIMT was measured from two consecutive heart beats.
2.5. Reproducibility
The intra- and interobserver variabilities of measurements were de-
termined for AoIMT variables in 27 patients. For intraobserver variabil-
ity, the same observer repeated the measurements after 1 week,
whereas interobserver variability was assessed from measurements
performed by two experienced independent observers. The intra- and
interobserver variabilities for AoIMT expressed as a coefﬁcient of varia-
tion (CV%) in this study were 11% and 10%, respectively.
2.6. Blood analyses
The plasma concentrations of creatinine, highly sensitive C-reactive
protein (hs-CRP), HDL, LDL and serum concentrations of cholesterol
and triglycerides were estimated by the Karolinska University laborato-
ry using standard methods (Unicel DXC 800 Synchron; Beckman Coul-
ter, Brea, CA, USA).
2.7. Single nucleotide polymorphism analysis
Genotypes were extracted from previously described genotyping
using the Illumina Human 610W-Quad BeadArrays (Illumina Inc., San
Diego, CA, USA) at the SNP technology platform at Uppsala University
[21]. In 338 patients, we studied the rs200991 SNP in the HIST1H2BN
locus and the rs4888378 SNP in the BCAR1-CFDP1-TMEM170A locus,
identiﬁed previously as determinants of carotid IMT [15]. The patients
in whom SNP analysis were performed were evenly spread throughout
the study. In some cases the analysis was not possible due to logistical
reasons. The Genome Studio software from Illuminawas used for geno-
type calling and quality control.
2.8. Statistical analyses
Analyses were performed using commercially available SPSS soft-
ware (version 22; IBM Corp., Armonk, NY, USA). Data are presented as
mean± SD or medians and (25–75th percentiles). For comparisons be-
tween groups, Student's t test and analysis of variance (ANOVA) were
used. Skewed variables were log transformed before analyses. Tukey's
test for post hoc analysis was performed in conjunction with ANOVA.
The Chi-squared test was used to analyze nominal or categorical vari-
ables. Correlations between the variables were estimated using
Pearson's product–moment correlation coefﬁcient (r). Univariate and
stepwise forward multivariate regression analyses were used to evalu-
ate the predictors of AoIMT. Colinearity was analyzed to assess the rela-
tionships between the variables included in the models. P b 0.05 was
considered signiﬁcant. In multivariate analysis, determinants of AoIMT
with a classiﬁcation cutoff of P b 0.10 were presented in the model.
Fig. 1. Intima-media thickness of the descending aorta (AoIMT) measurement in a short-axis view in diastole. Mean value of AoIMT measured by a semi-automated edge-detection
software has been reported in this study.
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The clinical characteristics and echocardiographic data according to
valve morphology are shown in Table 1. There were no differences in
weight, body surface area, cholesterol, LDL, HDL, angina, heart failure,
stroke/TIA, diabetes, smoking habits or ejection faction between BAV
and TAV patients. In all, 366 patients were classiﬁed according to the
TTE study protocol (Table 2). TAV patients displayed a thicker AoIMT
within respective valve pathology compared to BAV, but TAV patients
were signiﬁcantly older (AS 10 years, P b 0.001; AR 12 years, P b 0.001)
data not shown). In the AscAA andMIX groups there were no signiﬁcant
differences in AoIMT between the valve phenotype subgroups, but theseTable 1
Descriptive background and echocardiographic data.
All n= 368 BAV n= 210 TAV n= 158
P-value
BAV vs.
TAV
Age (years) 64.3 ± 12.6 60.2 ± 12.2 69.5 ± 11.0 b0.001
Height (m) 1.74 ± 0.10 1.75 ± 0.09 1.72 ± 0.10 0.001
BMI (kg/m2) 26.9 ± 4.4 26.3 ± 4.2 27.5 ± 4.7 b0.05
Inclusion SBP (mmHg) 141 ± 20 139 ± 20 144 ± 20 b0.01
Inclusion DBP (mmHg) 80 ± 13 81 ± 12 77 ± 13 0.001
Mean BP (mmHg) 100 ± 12 101 ± 12 100 ± 13 ns
Creatinine (μml/L) 81 (70–91) 80 (69–89) 82 (70–92) ns
hsCRP (mg/L) 1.5 (0.6–3.1) 1.1 (0.5–2.9) 1.8 (0.8–3.6) 0.001
Triglycerides (mml/L) 1.0 (0.8–1.5) 1.0 (0.8–1.6) 1.0 (0.7–1.5) ns
Male gender 245 (67%) 148 (71%) 97 (61%) ns
Myocardial infarction 20 (5%) 6 (3%) 14 (9%) b0.05
Hypertension 195 (53%) 102 (49%) 93 (59%) b0.05
Echocardiographic data
AoIMT (mm) 1.37 ± 0.33 1.30 ± 0.33 1.44 ± 0.31 b0.001
LVEDD (mm) 52 ± 9 52 ± 9 52 ± 10 ns
Pmax (mmHg) 58 ± 37 62 ± 38 52 ± 26 b0.01
AVA (cm2) 1.6 ± 1.2 1.5 ± 1.1 1.7 ± 1.3 b0.05
AR grade: 0/1/2/3 (%) (23/44/12/21) (24/44/13/18) (20/44/12/25) ns
Aorta ascendens/BSA
(mm/m2)
20 ± 5 20 ± 6 21 ± 5 ns
Aorta descendens
(mm) 24 ± 3 23 ± 3 25 ± 3 0.001
Aorta descendens/BSA
(mm/m2) 12 ± 2 12 ± 2 13 ± 2 0.001
BAV, bicuspid aortic valve; BMI, body mass index; hsCRP, high sensitivity C-reactive pro-
tein; TAV, tricuspid aortic valve; AoIMT, Aortic intima-media thickness; AVA, aortic
valve area; LVEDD, left ventricular end-diastolic diameter; Pmax, aortic valve peak gradi-
ent; Values are expressed as mean ± SD, median and (25th–75th percentile) or as n (%)
or %.constituted fewer patients. The age difference between TAV and BAV pa-
tientswas signiﬁcant in theAscAAgroup (TAV8years older, P b 0.02) but
not in the MIX group, data not shown.
3.1. Genetic associations
Table 3 showsAoIMT values according to the alleles in SNPs.We only
found signiﬁcant differences between the genotype groups for the
rs200991 SNP. There were very few patients with an AA nucleotide al-
lele pair conﬁguration, as expected according to Hardy–Weinberg equi-
librium [22]. On post hoc analysis between groups, a non-signiﬁcant
trend (P= 0.098) towards a thicker AoIMT was noted in patients with
the CC conﬁguration. In a subgroup analysis of men and women, there
were no signiﬁcant differences in the AoIMT values between genotypes
in the SNPs (data not shown). When the BAV and TAV groups were an-
alyzed separately, only the patients with a TAV showed a difference be-
tween the rs200991 alleles. Patients with a CC allele conﬁguration
displayed a trend towards a thicker AoIMT vs. the AC allele. Analysis
of the AA, AC, and CC allele groups showed signiﬁcant differences in
the ejection fraction (AA vs. AC, 50% vs. 59%; P = 0.043; data not
shown). There were no signiﬁcant differences in any of the other vari-
ables between the groups.
3.2. Correlations
There were signiﬁcant correlations (P b 0.05) between AoIMT and
age (r = 0.48) and hsCRP (r = 0.11). Descending aortic dimension
was age-dependent (r= 0.62, P b 0.001)).
For further analysis,we divided the patients into two groups: A allele
(shaded areas in Table 3) vs. non A allele in the rs200991 locus. The re-
sults of the univariate regression analysis for AoIMT are shown in
Table 4, there were no associations between height, hypertension,Table 2
Intima-media thickness in the descending aorta in relation to valve pathology and
morphology.
BAV AoIMT (mm) TAV AoIMT (mm) P-value BAV vs. TAV
AS n= 203 1.36 ± 0.31 1.53 ± 0.29 b0.001
AR n= 77 1.10 ± 0.25 1.26 ± 0.23 b0.01
AscAA n= 55 1.36 ± 0.36 1.54 ± 0.47 ns
MIX n= 31 1.21 ± 0.29 1.35 ± 0.29 ns
AS, aortic stenosis; AR, aortic regurgitation; AscAA ascending aortic aneurysm;MIX,Mixed
pathology; mean ± SD.
Table 3
Intima-media thickness in the descending aorta in relation to alleles (AA, AG, GG; AA, AC, CC) of selected single-nucleotide polymorphisms and valve morphology.
Genotype
All AoIMT (mm) BAV AoIMT (mm) TAV AoIMT (mm)
Allele
ANOVA n ANOVA n ANOVA n
rs488378 AA ns 52 1.38 ± 0.30 ns 28 1.33 ± 0.28 ns 24 1.42 ± 0.32
AG 163 1.39 ± 0.31 93 1.33 ± 0.35 70 1.45 ± 0.25
GG 122 1.36 ± 0.36 70 1.28 ± 0.32 52 1.45 ± 0.39
rs200991 AA 0.063 5 1.54 ± 0.27 ns 3 1.45 ± 0.13 0.042‡ 2 1.68 ± 0.44
AC 89 1.31 ± 0.29 56 1.30 ± 0.32 33 1.33 ± 0.26
CC 243 1.40 ± 0.34 132 1.32 ± 0.34 111 1.48 ± 0.32
AoIMT, aortic intima-media thickness; BAV, bicuspid aortic valve; TAV, tricuspid aortic valve; n, number of patients; ANOVA, analysis of variance. Tukey's test for post hoc analysis between
groups, ‡CC vs. AC (P= 0.056). For further analysis, we divided the patients into two groups: A allele (AA and AC) vs. non A allele (CC) in the rs200991 locus.
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AoIMT for the whole group or BAV/TAV separately. In our multivariate
model, we chose variables of clinical relevance or variables shown to
be associated with CIMT or AoIMT in previous studies, such as smoking
and hsCRP. As a marker of AS, we choose only Pmax because there is
strong correlations between all the other AS variables. For AR, we in-
cluded only the AR grade in the model. We used the MBP to represent
the SBP and DBP. Gender is a known determinant of CIMT and was in-
cluded in the multivariate model, despite it not being signiﬁcant in the
univariate analysis. The multivariate analysis for the whole group
showed that AoIMT was associated with age and male gender
(Table 5). When the BAV and TAV subgroups were analyzed separately,
age was still the main predictor of AoIMT in both groups. The rs200991
SNP genotypewas signiﬁcant (P=0.034) for the TAV group of patients,
and the creatinine level was signiﬁcant for the BAV group (P= 0.019).
Smoking, Pmax and hsCRP, were not associated with AoIMT in the mul-
tivariate analysis.
4. Discussion
Descending aortic IMT in patientswith aortic valve stenosis or regur-
gitation and/or AscAA, but without signiﬁcant CAD, is mainly deter-
mined by age and gender, and is not inﬂuenced by the presence of a
BAV, known to be associated with aortopathy. In patients with a TAV,
we found IMT in the descending aorta to be associated with theTable 4
Univariate analysis of determinants of the aortic intima-media thickness.
All BAV TAV
βeta P βeta P βeta P
Age 0.482 b0.001 0.474 b0.001 0.402 b0.001
Male gender −0.006 0.910 −0.028 0.689 0.070 0.384
Inclusion SBP 0.080 0.126 0.150 0.030 −0.080 0.322
Inclusion DBP 0.155 0.003 0.197 0.004 0.205 0.010
Mean BP 0.151 0.004 0.214 0.002 0.101 0.208
Ever smoker 0.134 0.011 0.170 0.015 0.124 0.123
Creatinine 0.115 0.029 0.126 0.071 0.065 0.419
lnhsCRP 0.143 0.006 0.092 0.187 0.139 0.086
lnTrigycerides 0.036 0.488 0.141 0.041 −0.084 0.300
HDL 0.117 0.026 0.229 0.001 −0.011 0.896
Pmax 0.173 0.001 0.151 0.032 0.289 b0.001
AR (0–3) −0.248 b0.001 −0.251 b0.001 −0.289 b0.001
AVA −0.248 b0.001 −0.240 0.001 −0.328 b0.001
AoDesc 0.352 b0.001 0.347 b0.001 0.290 0.001
AoDesc/BSA 0.329 b0.001 0.316 b0.001 0.278 0.002
BAV −0.209 b0.001 – – – –
rs200991A −0.098 0.073 −0.028 0.699 −0.168 0.043
AoDsc, descending aortic diameter; AoIMT, aortic intima-media thickness; AR, aortic re-
gurgitation; AVA, aortic valve area; BAV, bicuspid aortic valve; BSA, body surface area;
DBP, diastolic blood pressure; HDL, high-density lipoprotein; EF, ejection fraction; Mean
BP, mean blood pressure; LVEDD, left ventricular end-diastolic diameter; Pmax, aortic
valve peak gradient; SBP, systolic blood pressure; TAV, tricuspid aortic valve; lnhsCRP, nat-
ural logarithm of highly sensitive C-reactive protein level; lnTrigycerides, natural loga-
rithm of triglyceride levels; rs200991A, A allele rs200991.rs200991 SNP genotype in the HIST1H2BN locus, recently identiﬁed as
a genetic determinant of CIMT.
To the best of our knowledge, this is the ﬁrst study examining IMT in
the descending aorta with a focus on possible associations with aortic
valve phenotype and aortic valve disease.Wewere especially interested
to explore whether BAV morphology, known to be associated with
aortopathy [1,23,24] and abnormal, strong helical ﬂow pattern in the
entire aorta [8], has an impact on AoIMT. In our study of 368 patients
we found no correlations between AoIMT and valve phenotype, vari-
ables of AS or AR and in multivariate analysis. The difference in AoIMT
seen between the BAV and TAV groups could be explained mainly by
a difference in age. Although impairments of elastic properties of the de-
scending aorta have been identiﬁed in patients with a BAV [9,11], it
seems not associated with dilatation or altered AoIMT in this aortic seg-
ment as shown in our study and by others [10]. Although themain focus
of this study was the descending aorta, it can be mentioned that histo-
logical analysis of the ascending aorta in patients with BAV and AscAA
have shown less thinning of IMT [25] and fewer intimal changes [26]
comparedwith patients with a TAV and AscAA. Our group has previous-
ly examined the genetic, molecular and biomechanical properties of the
ascending aorta in patients with AscAA in the ASAP patient population
and found signiﬁcant differences between BAV and TAV. A combined
proteomic and transcriptomic approach showed that AscAA formation
in patients with BAV and TAV involves different biological pathways
leading to the same phenotype [27]. Also BAV patients have an impaired
mechanism for the splicing of extra domain A of ﬁbronectin, supporting
that dilatation of the ascending aorta relates to an inherent tissueweak-
ness in BAV patients [28]. The examination of sections of aneurysmal
aortic tissue in BAV patients showed a higher macroscopic strength,
caused by an increased collagen-related stiffness, but the elastin-
related stiffness was similar in BAV and TAV AscAAs [1]. The function
of the ascending aorta in vivo has been extensively examined by others
[2–4].
It is debated whether BAV aortopathy is caused by a genetic predis-
position and/or the result from altered blood ﬂow with proponents of
both theories. A combination of genetic, ﬂow and environmental factors
in the individual patient is probably responsible for AscAA formation
[29]. The fact that microanatomy in the descending aorta (AoIMT) did
not differ between BAV and TAV does not exclude differences in aortic
function, or inherent tissue weakness as the etiology of BAV aortopathy
[30].
IMT in the aorta has been studied mainly in the abdominal segment.
An increase of IMT in this vessel with age can be seen even in neonates
of different gestational ages [31]. In our study male gender was a signif-
icant positive determinant of AoIMT, even after correcting for age, as the
male subjects were younger than the female ones (62 ± 13 vs. 69 ±
10 years). We found no correlations with known atherosclerotic risk
factors such as cholesterol, LDL, HDL, or triglycerides, probably because
we selected low-risk patients lacking signs of CAD, and with lipid levels
generally within normal limits. Although there are known to be associ-
ations between the hsCRP concentration and aortic stiffness [32], we did
Table 5
Multivariate analysis of determinants of the aortic intima-media thickness.
All (R2 = 0.241) BAV (R2 = 0.252) TAV (R2 = 0.181)
βeta P R2 change βeta P R2 change βeta P R2 change
Age (years) 0.467 b0.001 0.214 0.419 b0.001 0.217 0.337 b0.001 0.248
Male gender 0.121 0.020 0.012
Creatinine (μml/L) 0.159 0.019 0.024
HDL 0.119 0.087 0.013
AR (grades 0–3) −0.094 0.079 0.008 −0.044 0.069 0.020
rs200991A −0.095 0.059 0.008 −0.166 0.034 0.027
Mean BP (mm Hg) 0.119 0.082 0.013
BAV
AoIMT, aorta intima-media thickness; AR, aortic regurgitation; BAV, bicuspid aortic valve; BSA, body surface area; HDL, high-density lipoprotein; TAV, tricuspid aortic valve; rs200991A, A
allele of the rs200991 SNP; Mean BP, mean blood pressure.
78 J. Petrini et al. / IJC Heart & Vasculature 11 (2016) 74–79not ﬁnd the hsCRP level to be a signiﬁcant predictor of AoIMT after
correcting for age in our patients. As far as we know, an association be-
tween IMT in the descending aorta and hsCRP levels has not been stud-
ied yet.
After adjusting for age and traditional risk factors, the rs200991 SNP
became a signiﬁcant determinant of AoIMT only among patients with a
TAV. Gertow et al. reported a positive association for the A allele on
CIMT values among patients with known multiple cardiovascular risk
factors [15], whereas we found a negative association in patients with
aortic valve disease, but otherwise low risk of atherosclerosis, without
CAD and lipids levels close to normal limits. Needless to say, larger
studies are required to obtain ﬁrm conclusions in different patient
populations.
The methodology of measuring IMT in the aorta has varied in differ-
ent studies and different IMT variables have been reported, namely the
maximal and/or mean IMT. Inmost studies, single calipers applied to B-
or M-mode images have been used [32,33]. There are few publications
on measuring the aortic IMT using semi-automated edge-detection
methods in a 10-mm-wide vessel segment, reporting mean IMT value
[34].
Although a long-axis image of vessels is a standard projection for
measurements of IMT, however, there are reports on AoIMT measure-
ments in the transverse plane, which has been used in this study [35,
36]. The descending aorta has a diameter of approximately 21–26 mm
with a large curvature allowing IMTmeasurement over a 10-mm sector
on the short axis image. CT and MRI have the advantage of imaging the
whole aorta as well as the entire circumference of the vessel. However
the spatial resolution is considerably lower [37,38], making echocardi-
ography a method of choice for IMT measurements.5. Limitations
Using an anatomical landmark, such as the left atrium instead of a
ﬁxed distance from the teeth, would have compensated for patient
height and ensured that AoIMT was analyzed in the same region in all
patients. Due to multiple testing there is always a risk of type B error,
whichwe tried to avoid by limiting the number of variables tested keep-
ing the ratio between number of patients and independent variables at
b10 also in the BAV group.6. Conclusion
Intima-media thickness of the descending aorta is not directly affect-
ed by aortic valve morphology (BAV/TAV); age is themain determinant
of AoIMT. Our results regarding AoIMT do not exclude differences in
aortic function, or inherent tissue weakness as the etiology to BAV
aortopathy. Our study also identiﬁed a genetic determinant of AoIMT
in patients with a TAV, while in patients with a BAV the AoIMT was as-
sociated with creatinine levels.Conﬂict of interest
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